Completed PHASE4 INTERVENTIONAL 4-arm NCT01851863

Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia

Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia: A Randomized Comparison of Different Prescribing Behaviors

Sponsor: RenJi Hospital

Conditions Compliance Depression Dyspepsia

Interventions Flupentixol-Melitracen(psychological and GI) + Omeprazole Flupentixol-Melitracen(psychological) + Omeprazole Flupentixol-Melitracen(without explanation) + Omeprazole Omeprazole

Updated 5 times since 2017 Last updated: Feb 10, 2015 Started: May 31, 2013 Primary completion: Jun 30, 2014 Completion: Jun 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01851863, this PHASE4 trial focuses on Compliance and Depression and remains completed. Sponsored by RenJi Hospital, it has been updated 5 times since 2013, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

May 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

RenJi Hospital

Data source: RenJi Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China